All studies
Not yet recruitingOBSERVATIONAL

Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer Progression

This study is for women aged 35 and over who are experiencing unusual bleeding from their womb (uterus). Researchers will collect urine samples to measure hormone levels and ask participants to track their bleeding. They will also be testing a monitoring device called Mira to see how easy and helpful it is to use. The study aims to understand the link between hormones and uterine conditions, including cancer, as well as to improve our understanding of women's menstrual health and how to support it.

At a glance

Status
Not yet recruiting
Sponsor
University of British Columbia
Enrolment target
50
Start
01 May 2026
Estimated completion
01 Sep 2026

What is this study about?

This study is investigating different types of hormones found in urine from women who are experiencing abnormal uterine bleeding. Abnormal uterine bleeding means bleeding from the womb that is different from what is normal for you, such as very heavy periods, bleeding between periods, or bleeding after menopause. The researchers want to see if the levels of certain hormones can help them understand the progression of uterine cancer and other related conditions like endometrial hyperplasia, which is a thickening of the lining of the womb.

They also want to learn how easy and helpful it is for women to use a device called a Mira monitor to track their hormones and periods at home. This is important because understanding your own cycle can be a big step towards better managing your health. By collecting this information, the study hopes to find new ways to detect uterine problems earlier or understand how they develop.

Ultimately, the goal is to improve how we diagnose and manage conditions affecting the womb. This research could lead to better tools for women to monitor their health and for doctors to provide more targeted care, helping women maintain good reproductive health.

Key takeaways

  • A study for women aged 35+ with unusual womb bleeding.
  • Aims to understand hormones and uterine cancer progression.
  • Involves home collection of urine and using a monitoring device.
  • Checks women's understanding of their menstrual health.
  • Could help improve future diagnosis and care for womb conditions.

Who may be eligible?

To join this study, you need to be a woman who is 35 years old or older and has experienced bleeding from your womb (uterus) that is unusual for you. This could mean very heavy periods, bleeding between periods, or any other bleeding that concerns you.

However, you cannot take part if you are currently pregnant or become pregnant during the study. You also can't participate if you've had surgery that would affect your menstrual cycle, such as a hysterectomy (removal of the womb) or removal of both ovaries.

Finally, if you are currently taking, or have taken in the last three months, any medications that affect your ovulation or hormones – like the contraceptive pill, hormone replacement therapy, or fertility treatments – this study might not be suitable for you.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. Are you 35 years old or older?
  2. Have you experienced unusual bleeding from your womb?
  3. Are you NOT currently pregnant or planning to become pregnant during the study?
  4. Have you NOT had surgery that affects your menstrual cycle (like hysterectomy or ovary removal)?
  5. Have you NOT taken hormone-affecting medications (like the pill or HRT) in the last 3 months?
Answer every question to see your result.

What does participation involve?

If you decide to take part, you will be asked to collect urine samples at home and use a Mira monitor device. You'll also be asked to track your bleeding and provide information about your menstrual health. The researchers will check how well you understand menstrual health at the beginning and end of the study. The total duration of your involvement isn't specified, but it will involve consistently collecting data over a period related to your menstrual cycle.

Potential risks and benefits

Potential benefits of taking part include contributing to important research that could improve understanding and care for women with uterine bleeding and related conditions. You might also gain a better understanding of your own menstrual health. There are no known significant risks as the study primarily involves collecting urine samples and using a monitoring device at home. You are always free to stop participating in the study at any time without needing to give a reason.

Locations (1)

  • Vancouver General Hospital Research Pavillion
    Verified postcode
    Vancouver, Canada

Common questions

What kind of 'abnormal bleeding' are you interested in?

We are looking for women experiencing any bleeding from their womb that is different from their usual pattern, such as heavy periods, bleeding between periods, or bleeding after menopause.

What is a Mira monitor?

The Mira monitor is a device used to track hormones in your body, which can help you understand your menstrual cycle better.

Will I have to go to a clinic?

The study involves collecting urine samples and using a monitor at home. Clinic visits are not mentioned as part of the primary activities.

How long will I be in the study?

The exact duration of participation isn't specified, but it will involve tracking your cycles and collecting data over some time.

Will I find out my hormone results?

The study aims to collect this data for research purposes, but whether individual participants will receive their specific results is not mentioned. You can ask the study team about this.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Interested in taking part?

Register your interest

Share your details and the research team for "Measurement of Urinary Hormones in Patients With Abnormal Ut…" will contact you if you may be eligible. Always speak to your GP before agreeing to take part.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.